We are a biotechnology company that is focused on the discovery and development of novel molecules and related diagnostics to treat high unmet medical needs in oncology and immunology.
We are a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system, or CNS, disorders with limited or no approved treatment options.
Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).
We are a returns-focused company formed to pursue oil and natural gas mineral and royalty interest opportunities in leading oil-weighted onshore domestic resource plays.
Our goal is to become a diversified high-tech Internet company targeting fast growing technology sectors primarily in China. Our business segments primarily consist of online games and electric vehicles through our joint venture agreement with Faraday&Future Inc. or F&F.
We are a rapidly-growing online peer-to-peer lending marketplace facilitating loans between borrowers and investors, providing borrowers accessible, affordable credit and offering investors attractive risk-adjusted returns. From our inception through June 30, 2018, we have matched loan transactions with an aggregate value of approximately RMB4.99 billion ($743.53 million). We primarily conduct our businesses in Guangdong Province, China and service exclusively Chinese borrowers and investors.
We are a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
We are a rapidly-growing manufacturer and distributor of environmentally-friendly, single-use disposable products primarily used in restaurants and foodservice settings. We supply a wide range of products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery and straws.
We are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.
Independent insurance distribution firm.
Progyny is a leading benefits management company specializing in fertility and family building benefits solutions in the United States.
We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.
We are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.
We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages
We are an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing, or TFF, technology platform.
We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
We have built and operate an open end-to-end cloud robot system, and offer it as a service to the world.
We are a growth-oriented, independent oil and natural gas company focused on rapidly growing our reserves, production and cash flow through the acquisition, exploration, development and production of oil, natural gas, and natural gas liquids, or NGLs, reserves in the Permian Basin.
UPLISTING: We are FinTech company and payment facilitator (“PayFac”) that focuses on a suite of products in the merchant services and payment facilitator verticals and provides integrated business solutions to merchants throughout the United States.
Aesthetic medical service company.
We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
FOLLOW-ON OFFERING: Nasdaq uplisting; VerifyMe, Inc. (“VerifyMe,” the “Company,” “we” or “us”) is a developmental stage technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products.
We are a pioneer and leader in China’s used car financing market, focusing on facilitating loans from financial institutions to prime borrowers in used car transactions.
We are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.
We operate the largest co-working space community in China in terms of the number of co-working spaces, aggregate managed area and number of cities covered in China as of September 30, 2019, according to Frost & Sullivan.
We are a high-growth, healthcare and wellness company that sells topical products to improve immune health, neuromuscular health and skin barrier health.
We are a provider of healthcare information, education, and training services to healthcare professionals and the public in China.
AESE operates a premier public esports and entertainment company, consisting of the Allied Esports and World Poker Tour businesses.
Uplisting, Follow-on Offering: Unit offering containing one common and one warrant, the common stock and warrants will be issued separately and will be immediately separable upon issuance.
Muscle Maker is a fast casual restaurant concept that specializes in preparing healthy-inspired, high-quality, fresh, made-to-order lean, protein-based meals featuring chicken, seafood, pasta, hamburgers, wraps and flat breads.
UP-LISTING/FOLLOW-ON OFFERING: We have designed and developed, and now own and operate, a business-to-business, web-based marketplace focused on the United States pharmaceutical industry. Our core service brings the nation’s independent pharmacies and accredited national suppliers of pharmaceuticals together to provide efficient and transparent buying and selling opportunities.
We are a leading independent online insurance product and service platform in China that is not affiliated with insurance companies or other insurance industry participants.
FOLLOW-ON OFFERING: Preferred stock. Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates.
We are a clinical-stage biopharmaceutical company focused on achieving efficient development of products that address significant unmet needs in Central Nervous System ("CNS") disorders and other rare disorders.
LMP, through its wholly owned subsidiaries, currently offers our customers the opportunity to buy, sell, rent and subscribe for, and obtain financing for automobiles both online and in person.